Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,216 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Wound-Healing and Skin-Moisturizing Effects of Sasa veitchii Extract.
Ikarashi N, Kaneko M, Fujisawa I, Fukuda N, Yoshida R, Kon R, Sakai H, Sugiyama K, Kamei J. Ikarashi N, et al. Among authors: fukuda n. Healthcare (Basel). 2021 Jun 19;9(6):761. doi: 10.3390/healthcare9060761. Healthcare (Basel). 2021. PMID: 34205315 Free PMC article.
Phase 2 study of axicabtagene ciloleucel in Japanese patients with relapsed or refractory large B-cell lymphoma.
Kato K, Makita S, Goto H, Kanda J, Fujii N, Shimada K, Akashi K, Izutsu K, Teshima T, Fukuda N, Sumitani T, Sumi H, Shimizu S, Kakurai Y, Yoshikawa K, Tobinai K, Usui N, Hatake K. Kato K, et al. Among authors: fukuda n. Int J Clin Oncol. 2022 Jan;27(1):213-223. doi: 10.1007/s10147-021-02033-4. Epub 2021 Oct 1. Int J Clin Oncol. 2022. PMID: 34599413 Free PMC article. Clinical Trial.
A phase 2 study of axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma in Japan: 1-year follow-up and biomarker analysis.
Kato K, Fujii N, Makita S, Goto H, Kanda J, Shimada K, Akashi K, Izutsu K, Teshima T, Fukuda N, Sumitani T, Nakamura S, Sumi H, Shimizu S, Kakurai Y, Yoshikawa K, Tobinai K, Usui N, Hatake K. Kato K, et al. Among authors: fukuda n. Int J Hematol. 2023 Mar;117(3):409-420. doi: 10.1007/s12185-022-03494-7. Epub 2022 Nov 18. Int J Hematol. 2023. PMID: 36399286 Clinical Trial.
A longer-chain acylated derivative of Dictyostelium differentiation-inducing factor-1 enhances the antimalarial activity against Plasmodium parasites.
Yoshida N, Kikuchi H, Hirai M, Balikagala B, Anywar DA, Taka H, Kaga N, Miura Y, Fukuda N, Odongo-Aginya EI, Kubohara Y, Mita T. Yoshida N, et al. Among authors: fukuda n. Biochem Pharmacol. 2024 Apr 30;225:116243. doi: 10.1016/j.bcp.2024.116243. Online ahead of print. Biochem Pharmacol. 2024. PMID: 38697310
1,216 results